Acadia Pharmaceuticals Inc (ACAD)
Operating Income Growth
16.87%
Quarterly · Period ending:
ACAD Operating Income Growth
Year-over-year change vs the same period a year earlier
Latest reported16.87%period ending
Latest reported16.87%period ending
ACAD Quarterly Operating Income YoY % (-97.77% → 16.87%)
Year-over-year change
High-resolution chart · PNG
ACAD operating income growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Income Growth |
|---|---|
| 16.8716% | |
| -123.9295% | |
| -88.6706% | |
| 12.9946% | |
| 6.364% | |
| 26.8245% | |
| 339.2829% | |
| 154.7701% | |
| 902.2061% | |
| 128.3853% | |
| 175.8613% | |
| -87.1833% | |
| 109.025% | |
| 52.5872% | |
| -3.1484% | |
| -101.7254% | |
| 23.0113% | |
| -69.2566% | |
| 33.5085% | |
| 82.1872% | |
| 0.6839% | |
| 25.4069% | |
| -19.0837% | |
| -89.1174% | |
| 22.9125% | |
| -2.1464% | |
| 16.1665% | |
| 25.8687% | |
| 10.9053% | |
| -59.8606% | |
| 3.9052% | |
| 7.6005% | |
| 6.3638% | |
| 38.2711% | |
| 10.5099% | |
| 8.409% | |
| 4.851% | |
| -76.6862% | |
| -71.691% | |
| -85.648% | |
| -82.0974% | |
| -23.9446% | |
| -59.5693% | |
| -56.0294% | |
| -81.8211% | |
| -125.8158% | |
| -134.7501% | |
| -131.1905% | |
| -137.2283% | |
| -191.3368% | |
| -78.3839% | |
| -349.1483% | |
| -68.6683% | |
| 1.0753% | |
| -28.3214% | |
| 52.7391% | |
| 17.5425% | |
| -6.3129% | |
| -118.243% | |
| -20.0613% | |
| -53.2588% | |
| -6.6412% | |
| 434.5853% | |
| 51.6526% | |
| 66.4925% | |
| 63.7658% | |
| 38.7376% | |
| 45.4658% | |
| 32.6734% | |
| 17.7485% | |
| 24.0257% | |
| 10.0822% | |
| -51.0989% | |
| -37.0772% | |
| -38.0443% | |
| -42.6988% | |
| 2.0289% | |
| -33.198% | |
| -26.6367% | |
| 2.1346% | |
| -98.0997% | |
| -74.1319% | |
| -43.5188% | |
| -102.6493% | |
| -10.3376% | |
| 9.8228% | |
| 61.3185% | |
| -442.7572% | |
| -102.6688% | |
| -97.7677% |